Invitation to presentation of Orexo´s Q3 Interim Report, on November 3 at 1 pm CET
Uppsala, Sweden – October 22, 2021 – As previously communicated Orexo will announce the Q3 2021 Interim Report, on November 3 at 8 am CET. The same day at 1 pm CET analysts, investors and media are invited to attend a presentation where Nikolaj Sørensen, CEO, Dennis Urbaniak, EVP Digital Therapeutics and Joseph DeFeo, CFO, will present the report. After the presentation a Q&A will be held. Questions can also be sent in advance to ir@orexo.com, no later than 11 am CET. Please view the instructions below on how to participate. Video link: https://tv.streamfabriken.com/orexo-q3-2021